The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Gene, cellular and tissue-based therapies hold tremendous promise for addressing some of the most problematic diseases, including those without treatment options and rare genetic conditions. Developers of these therapies should work with regulators beginning at the earliest stages of development. The interactions with regulators on how to design the development program allows for a facilitation of the approval process and ultimately bringing the treatment to the patients.
